Europe & Central Asia (IDA & IBRD countries) vs Turkmenistan: Immunization, HepB3
Immunization, HepB3 over time
- Europe & Central Asia (IDA & IBRD countries)
- Turkmenistan
How they compare
Turkmenistan currently reports 99.0% against 92.7% in Europe & Central Asia (IDA & IBRD countries), a difference of 6.3%.
That makes Turkmenistan's figure about 1.1 times Europe & Central Asia (IDA & IBRD countries)'s.
Across all 23 years both countries report, Turkmenistan has been ahead every year.
Europe & Central Asia (IDA & IBRD countries) ranks 4th and Turkmenistan ranks 1st of 47 groups.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe & Central Asia (IDA & IBRD countries) | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.5% | 97.1% | 8.6% | Turkmenistan |
| 2010s | 92.0% | 98.0% | 6.0% | Turkmenistan |
| 2020s | 93.3% | 98.2% | 4.9% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Europe & Central Asia (IDA & IBRD countries) or Turkmenistan?
- Turkmenistan, at 99.0% against 92.7% in Europe & Central Asia (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hepb3 between Europe & Central Asia (IDA & IBRD countries) and Turkmenistan?
- 6.3%, with Turkmenistan ahead.
- How many years of comparable data are there for Europe & Central Asia (IDA & IBRD countries) and Turkmenistan?
- 23 years are reported by both, from 2002 to 2024.
- How do Europe & Central Asia (IDA & IBRD countries) and Turkmenistan rank globally for immunization, hepb3?
- Europe & Central Asia (IDA & IBRD countries) ranks 4th and Turkmenistan ranks 1st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.